At Spirify Pharma Inc, our innovative compounds will change the landscape of pain and depression treatments.

Our platform has a wide range of features that were created with an aim to help address some of the greater challenges of drug development in those fields. In order to empower our patients to do better, Spirify Pharma Inc is continually building upon its technology.

Utilizing a platform approach for a class of proprietary modulators of D-Serine levels in the CNS, Spirify intends to bring potent fast-acting orally available candidate molecules into clinical development in CRPS, other forms of neuropathic pain, depression, neurodegenerative diseases, and others.